Sanchez P L, Morinigo J L, Pabon P, Martin F, Piedra I, Palacios I F, Martin-Luengo C
Cardiac Unit, University Hospital, Salamanca, Spain.
Heart. 2004 Mar;90(3):264-9. doi: 10.1136/hrt.2002.007443.
To determine the differences in the inflammatory status between diabetic and non-diabetic patients and to evaluate the usefulness of C reactive protein, fibrinogen, and leucocyte count as predictors of death in diabetic patients with unstable coronary disease.
Nested case-control comparisons of the inflammatory status between diabetic and non-diabetic patients. Prospective cohort analysis of C reactive protein concentration, fibrinogen concentration, and leucocyte count as predictors of cardiovascular death in diabetic patients.
Coronary care unit in Spain.
83 diabetic patients with non-ST elevation acute coronary syndrome and 83 sex and aged matched patients selected from 361 non-diabetic patients with non-ST elevation acute coronary syndrome.
Plasma concentrations of C reactive protein and fibrinogen, and leucocyte count. Investigators contacted patients to assess clinical events.
Concentrations of C reactive protein and fibrinogen, and leucocyte count on admission were higher in diabetic than in non-diabetic patients (7 mg/l v 5 mg/l, p = 0.020; 3.34 g/l v 2.90 g/l, p = 0.013; and 8.8 x 10(9)/l v 7.8 x 10(9)/l, p = 0.040). Among diabetic patients, these values were also higher in those who died during the 22 month follow up (13 mg/l v 6 mg/l, p = 0.001; 3.95 g/l v 3.05 g/l, p < 0.001; and 11.4 x 10(9)/l v 8.4 x 10(9)/l, p = 0.005). After adjustment for confounding factors, diabetic patients in the highest tertile of C reactive protein had a hazard ratio for cardiovascular death of 4.51 (95% confidence interval (CI) 1.62 to 12.55). Similar hazard ratios were for fibrinogen 3.74 (95% CI 1.32 to 10.62) and for leucocyte count 3.64 (95% CI 1.37 to 9.68).
Inflammation appears more evident in diabetic than in non-diabetic patients with acute coronary syndrome. C reactive protein concentration, fibrinogen concentration, and leucocyte count constitute independent predictors of cardiovascular death in diabetics with unstable coronary disease.
确定糖尿病患者与非糖尿病患者炎症状态的差异,并评估C反应蛋白、纤维蛋白原和白细胞计数作为不稳定型冠心病糖尿病患者死亡预测指标的效用。
糖尿病患者与非糖尿病患者炎症状态的巢式病例对照比较。对C反应蛋白浓度、纤维蛋白原浓度和白细胞计数作为糖尿病患者心血管死亡预测指标进行前瞻性队列分析。
西班牙冠心病监护病房。
83例非ST段抬高型急性冠脉综合征糖尿病患者以及从361例非ST段抬高型急性冠脉综合征非糖尿病患者中选取的83例性别和年龄匹配的患者。
C反应蛋白和纤维蛋白原的血浆浓度以及白细胞计数。研究人员联系患者以评估临床事件。
糖尿病患者入院时C反应蛋白和纤维蛋白原的浓度以及白细胞计数高于非糖尿病患者(分别为7mg/l对5mg/l,p = 0.020;3.34g/l对2.90g/l,p = 0.013;8.8×10⁹/l对7.8×10⁹/l,p = 0.040)。在糖尿病患者中,在22个月随访期间死亡的患者这些值也更高(分别为13mg/l对6mg/l,p = 0.001;3.95g/l对3.05g/l,p < 0.001;11.4×10⁹/l对8.4×10⁹/l,p = 0.005)。在对混杂因素进行校正后,C反应蛋白处于最高三分位数的糖尿病患者心血管死亡的风险比为4.51(95%置信区间(CI)1.62至12.55)。纤维蛋白原的类似风险比为3.74(95%CI 1.32至10.62),白细胞计数的风险比为3.64(95%CI 1.37至9.68)。
在急性冠脉综合征患者中,炎症在糖尿病患者中比在非糖尿病患者中更明显。C反应蛋白浓度、纤维蛋白原浓度和白细胞计数是不稳定型冠心病糖尿病患者心血管死亡的独立预测指标。